|
Toho Holdings Co., Ltd. is a Japanese pharmaceutical group operating through four main business segments. The pharmaceutical wholesale segment involves purchasing medicines and medical supplies from manufacturers and distributing them to hospitals, clinics, and pharmacies, with key subsidiaries including Toho Yakuhin, Kyushu Toho, and Seiel. The dispensing pharmacy segment operates insurance-based retail pharmacies through subsidiaries such as Pharma Daiwa, J. Mirai Medical, and Pharma Mirai, supported by management services from Pharma Cluster. In pharmaceutical manufacturing and sales, Kyosou Mirai Pharma produces generic drugs and contract-manufactures injectable medicines, while affiliated companies Aiyumi Pharmaceutical Holdings and Aiyumi Pharmaceutical engage in drug production. The other related businesses segment includes clinical pharmacology research, health information services, and e-commerce platforms like e-Health Shop and e-Healthcare. The group also provides data processing and core system services via Toho System Service and engages in real estate leasing through Square One. The company serves pharmaceutical manufacturers, healthcare facilities, and patients across Japan. Summarised from the annual report, fiscal year ended Mar 2026 |
Industry Medical Distribution | Homepage tohohd.co.jp |
| Sector Healthcare | IR page tohohd.co.jp | |
|
Tags
pharmaceutical wholesale, dispensing pharmacies, generic drugs, contract manufacturing, medical supplies, clinical research, healthcare it, real estate leasing, Toho Yakuhin, Kyushu Toho, Seiel, Koyo, Sakai Yakuhin, Pharma Daiwa, J. Mirai Medical, Pharma Mirai, Stretia, Aoba-do, K. Create, Toho System Service, Square One, Pharma Cluster, Kyosou Mirai Pharma, Aiyumi Pharmaceutical Holdings, Aiyumi Pharmaceutical, Tokyo Clinical Pharmacology Research Institute, Alf, Negit Research Institute, e-Health Shop, e-Healthcare
|
Press page tohohd.co.jp/news |
Metrics
| Valuation | |
|---|---|
| Market cap | ¥ 286.481B |
| Market cap (USD) | $ 1.791B |
| P/E | 16.61 |
| PEG | 1.99 |
| P/BV | 1.06 |
| P/S | 0.18 |
| P/OCF | 19.61 |
| P/FCF | 59.98 |
| Dividend yield | 4.2% |
| Turnover / mcap | — |
| Returns | |
|---|---|
| ROE | 6.6% |
| ROI | 6.3% |
| ROIC | 4.0% |
| Profit margin | 1.1% |
| Growth | |
|---|---|
| Revenue growing | Yes |
| Profits growing | No |
| Revenue up 3y | Yes |
| Revenue up 5y | Yes |
| Earnings growth 3y (net profit CAGR) | 8.3% |
| Quality | |
|---|---|
| Profitable | Yes |
| Margin expanding | No |
| Buying back stock | Yes |
| Diluting (TTM) | No |
| Debt/Equity | — |
| Podcast bulls (TTM) | Sign up |
| Podcast bears (TTM) | Sign up |
| Podcast sentiment (TTM) | Sign up |
| Podcast sentiment % (TTM) | Sign up |
| News sentiment (TTM) | 4 |
| Quality score | 5.6% |
| Insiders | |
|---|---|
| Buys, 1w | Sign up |
| Buys, 1m | Sign up |
| Buys, 1y | Sign up |
| Sells, 1w | Sign up |
| Sells, 1m | Sign up |
| Sells, 1y | Sign up |
Sign up to see this company's insider trades
| Figure | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 | FY 2013 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 1.553T | 1.518T | 1.477T | 1.389T | 1.266T | 1.21T | 1.264T | 1.222T | 1.213T | 1.231T | 1.308T | 1.162T | 1.19T | 1.14T |
| Net profit | 17.327B | 19.844B | 20.657B | 13.63B | 13.379B | 4.989B | 16.23B | 13.863B | 14.384B | 14.225B | 21.771B | 13.535B | 10.407B | 11.526B |
| Free cash flow | 9.73B | -32.432B | 56.153B | -2.528B | 12.139B | 3.044B | -3.055B | 9.629B | 42.972B | 7.501B | -4.129B | — | — | — |
| Figure | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 | FY 2013 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Share price | 4.761K | 4.46K | 3.653K | 2.35K | 1.85K | 2.03K | 2.267K | 2.762K | 2.506K | 2.33K | 2.408K | 2.029K | 2.184K | 2.176K |
| Price performance 12m | 0.07 | 0.22 | 0.55 | 0.27 | -0.09 | -0.1 | -0.18 | 0.1 | 0.08 | -0.03 | 0.19 | -0.07 | 0 | — |
Filed figures
Lines the statements and their notes report beside the headline figures, read from the filings' XBRL as filed (no restatement applied), with figures computed from one filing's own lines. Cash-flow lines carry their cash direction: an outflow is negative. Each period links to its filing; a figure's period, report date and tag are in its tooltip.
| Figure | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Balance sheet detail | ||||||||||
| Trade receivables (JPY) | 284B | 282B | 287B | 286B | 286B | 302B | 316B | 339B | 332B | 347B |
| ↳ YoY growth | -14.2% | -0.9% | +2.0% | -0.6% | +0.0% | +5.6% | +4.8% | +7.1% | -1.8% | +4.4% |
| ↳ 5y CAGR | -2.9% | +1.2% | +2.3% | +3.4% | +3.1% | +4.0% | ||||
| Borrowings, current (JPY) | 4.22B | 944M | 8.54B | 2.67B | 2.88B | 6.55B | 29.8B | 552M | 1.72B | 474M |
| Borrowings, non-current (JPY) | 17B | 20.9B | 25.7B | 39.3B | 39.1B | 32.6B | 6.47B | 28.2B | 17.6B | 7.04B |
| Bonds payable (JPY) | 15B | 15B | 28B | 20.1B | 20B | 20B | 20B | 22.1B | 13.1B | 1.75B |
| Lease liabilities (JPY) | 6.74B | 5.29B | 3.64B | 2.79B | 1.98B | 1.57B | 1.61B | 1.53B | 1.98B | 2.38B |
| Cash and deposits (JPY) | 32B | 67.9B | 79.6B | 84.2B | 93.1B | 94.3B | 86.2B | 133B | 86.5B | 87.4B |
| Intangible assets (JPY) | 7.3B | 5.16B | 3.98B | 4.6B | 5.11B | 5.18B | 5.38B | 5.64B | 6.09B | 8.08B |
| Net debt (borrowings + leases - cash) (JPY) | -4.01B | -40.8B | -41.8B | -39.5B | -49.2B | -53.5B | -48.3B | -103B | -65.3B | -77.5B |
| Cash flow detail | ||||||||||
| Operating cash flow (JPY) | 16.1B | 52B | 13.4B | 10.8B | 8.77B | 16.3B | -9M | 59.9B | -26.7B | 19.2B |
| Purchases of property, plant and equipment (JPY) | -7.16B | -8.46B | -2.8B | -11.9B | -4.14B | -3.62B | -1.64B | -2.51B | -4.06B | -6.22B |
| Purchases of intangible assets (JPY) | -1.4B | -550M | -1B | -1.98B | -1.58B | -581M | -880M | -1.28B | -1.7B | -3.29B |
| Change in receivables (cash effect) (JPY) | 47.1B | 2.47B | -5.36B | 1.7B | 1.02B | -16B | -14.6B | -20.4B | 4.29B | -14B |
| Change in inventories (cash effect) (JPY) | 1.65B | 499M | -5.39B | 2.91B | 1.14B | -3.86B | -10.9B | 4.37B | -3.49B | 1.38B |
| Change in payables (cash effect) (JPY) | -41.3B | 20.1B | 5.03B | -19.2B | 739M | 13B | 14.7B | 51.4B | -40.8B | 15.8B |
| Dividends paid (cash effect) (JPY) | -2.06B | -2.06B | -2.03B | -2.43B | -2.47B | -2.12B | -2.19B | -2.24B | -3.02B | -5.45B |
| Share buybacks (cash effect) (JPY) | -1M | -626M | -10B | -2.82B | -2M | 0.00 | -7.39B | -12B | -15B | -10B |
| Interest paid (cash effect) (JPY) | -193M | -122M | -74M | -54M | -81M | -78M | -71M | -62M | -47M | -57M |
| Income taxes paid (cash effect) (JPY) | -17.1B | -4.83B | -9.75B | -7.15B | -6.73B | -3.21B | -8.99B | -7.77B | -10.1B | -7.53B |
| Operating cash flow before change in receivables (JPY) | -31B | 49.5B | 18.8B | 9.12B | 7.75B | 32.4B | 14.6B | 80.3B | -31B | 33.3B |
| Free cash flow (OCF - PPE - intangibles) (JPY) | 7.5B | 43B | 9.63B | -3.06B | 3.04B | 12.1B | -2.53B | 56.2B | -32.4B | 9.73B |
| Income detail | ||||||||||
| Research and development expense (JPY) | — | — | — | — | — | — | 355M | 445M | 299M | 173M |
| Total comprehensive income (JPY) | 15.3B | 22.3B | 11.4B | 14.4B | 8.03B | 5.7B | 11.6B | 20.7B | 16.2B | 18.7B |
| Comprehensive income to owners (JPY) | 15.3B | 22.3B | 11.4B | 14.4B | 8.03B | 5.67B | 11.6B | 20.7B | 16.1B | 18.7B |
| Provision for credit losses (JPY) | 69M | 17M | -104M | 61M | 317M | -147M | 223M | -471M | 239M | -147M |
| Credit cost ratio (credit losses / average receivables) (%) | 0.0% | 0.0% | 0.0% | 0.0% | 0.1% | 0.1% | 0.1% | 0.1% | 0.1% | 0.0% |
| Segments | ||||||||||
| Medical Products Manufacturing And Sales · Segment revenue (JPY) | — | — | — | — | 8.09B | 9.09B | 9.94B | 10.6B | 11.5B | 11.6B |
| ↳ YoY growth | +12.4% | +9.4% | +6.5% | +8.2% | +0.9% | |||||
| Medical Products Manufacturing And Sales · Segment operating income (JPY) | — | — | — | — | 729M | 884M | 864M | 755M | 729M | 282M |
| Reported | Jun 29, 2017 | Jun 28, 2018 | Jun 27, 2019 | Jun 26, 2020 | Jun 29, 2021 | Jun 29, 2022 | Jun 29, 2023 | Jun 27, 2024 | Jun 25, 2025 | Jun 24, 2026 |
Sign up to see institutional holdings
Sign UpPodcast Mentions
Sign up to see podcast mentions and sentiment
Sign UpTimely disclosures published on TDnet, newest first, titles as filed in Japanese. The link opens the disclosure on TDnet. Filings with EDINET (periodic reports, extraordinary reports, offerings, holding and buy-back reports), newest first, titles as filed in Japanese. The link opens the filing on EDINET. Press releases from the company's own website, newest first.
このたび、当社の連結子会社である株式会社eヘルスケア(本社:東京都、代表取締役社長:井上 修、以下、「eヘルスケア」)が利用している外部メール配信サービス「ブラストメール」(運営会 社:株式会社ラクスライトクラウド、以下、「ラクスライトクラウド社」)に対し、第三者による 不正アクセスが発生しました。その結果、eヘルスケアが保有する情報の一部が外部に漏洩した可 能性があることが判明しましたのでお知らせいたします。 なお、ラクスライトクラウド社からの一次報告では、現時点で漏洩が確認された288契約のリス トの中に、eヘルスケアのIDは含まれておりません。しかしながら、今後の調査・精査により変動 する可能性があるともされており、eヘルスケアの配信先情報に漏洩がないことが確定したもので はありません。 関係者の皆様に多大なるご迷惑とご心配をおかけしておりますことを、深くお詫び申し上げます。 記
- 事案の概要と現在の状況 eヘルスケアでは、「ブラストメール」を用いて以下のメール配信を行っております。 ①eヘルスケア独自の医師向けアンケートサービスのメール配信 ②病院なびPRサービスの申込御礼メール配信(※東邦薬品株式会社及びその医薬品卸売事業子 会社のMSが営業窓口を担当) ラクスライトクラウド社より、不正アクセスによる個人情報漏洩の可能性について報告を受け、 eヘルスケアでは医師向けアンケートサービスを一時的に停止するとともに、個人情報保護委員会 へ報告を行いました。また、対象となるお客様への案内を順次進めております。 なお、eヘルスケアが運営する各種サービス本体(「病院なび」、「病院なびHPサービス」、「病 院なびPRサービス」)、及び当社グループの他システムは当該配信システムと完全に独立しており、 本件による影響はございません。
- 漏洩した可能性のある情報 医師氏名・メールアドレス 約8,000件(うち、病院なびPRサービス関係約1,000件) 医療機関名約1,000件 医師用アンケート管理画面URL 約7,000件 医師の生年月日約30名分 ※配信先情報に、住所・電話番号・クレジットカード情報は含まれておりません。
- 今後の対応 ラクスライトクラウド社の調査は継続中であり、今後、調査の進展により新たにお知らせすべき 事実が判明した場合には、速やかに公表いたします。 対象となるお客様におかれましては、不審なメール等にご注意いただきますようお願い申し上げ ます。また、万が一不審なメールを受信された場合は、記載されたURL等のクリックを避け、削除 していただきますようお願いいたします。
Prompts
Click prompts to add them under the company line, click again to take one out, then copy the result into your AI chat. Shared by Asian Century Stocks and Uncovered Thai Stocks. Thank you.
ETFs Holding Toho Holdings Co., Ltd.
Exchange-traded funds whose newest published daily portfolio holds one of the company's listings, largest weight first.
| ETF | Weight in ETF | Shares | Market value | As of |
|---|---|---|---|---|
| AVDV | 0.04% | 342,100 | $ 8.562M | Nov 16, 2026 |
| AVDS | 0.04% | 6,100 | $ 152.667K | Nov 16, 2026 |
| DFIS | 0.03% | 68,100 | $ 1.68M | Nov 12, 2026 |
| AVSD | 0.02% | 3,700 | $ 92.602K | Nov 16, 2026 |
| DFIC | 0.01% | 53,000 | $ 1.308M | Nov 12, 2026 |
| DFSI | 0.01% | 4,000 | $ 98.687K | Nov 12, 2026 |
| DFAX | 0.01% | 38,500 | $ 949.859K | Nov 12, 2026 |
| DISV | 0.00% | 8,400 | $ 207.242K | Nov 12, 2026 |
| DFAI | 0.00% | 17,300 | $ 426.82K | Nov 12, 2026 |
| AVDE | 0.00% | 16,600 | $ 415.456K | Nov 16, 2026 |
| AVIV | 0.00% | 400 | $ 10.011K | Nov 16, 2026 |